Hypomagnesemia in Type 2 Diabetes: A Vicious Circle?

Area of Science:

• Endocrinology
• Metabolic Diseases
• Molecular Biology

Background:

• Hypomagnesemia is linked to type 2 diabetes mellitus (T2DM) progression and complications.
• Patients with T2DM and hypomagnesemia exhibit impaired pancreatic beta-cell function and insulin resistance.

Purpose of the Study:

• To systematically review the molecular mechanisms linking magnesium (Mg2+) to insulin secretion and signaling in T2DM.
• To identify novel research directions and overlooked factors contributing to hypomagnesemia in T2DM.

Main Methods:

• Literature review and synthesis of existing research on magnesium's role in glucose metabolism and insulin homeostasis.
• Analysis of molecular pathways involving intracellular Mg2+ in pancreatic beta-cells and insulin signaling.

Main Results:

• Intracellular Mg2+ regulates key molecules in insulin secretion (glucokinase, ion channels) and insulin receptor autophosphorylation.
• Insulin influences Mg2+ homeostasis by regulating renal Mg2+ excretion via the TRPM6 channel.
• A vicious cycle exists where hypomagnesemia exacerbates insulin resistance, and insulin resistance lowers serum Mg2+.

Conclusions:

• Magnesium plays a critical role in both insulin secretion and insulin sensitivity.
• Understanding the bidirectional relationship between Mg2+ and insulin is crucial for managing T2DM.
• Further research is needed to explore novel therapeutic strategies targeting Mg2+ metabolism in T2DM.